Merck and Huma Therapeutics launch innovative app to support bladder cancer patients
Posted:
London headquartered Huma Therapeutics, together with Germany's Merck KGaA, has announced the launch of their innovative bladder cancer treatment companion app in the United Kingdom.
Leaders from across the NHS, government, industry and academia have called for a fundamental shift in how artificial intelligence is adopted across the health service, arguing that the NHS must move beyond isolated pilots and create clearer, faster routes to…
Health Innovation Kent Surrey Sussex (KSS) and Doctors Training have co-designed and co-delivered Generative AI (GenAI) training for NHS clinical staff, ensuring ethical, scalable, and high-quality workforce education.
Read more here.